Maze Therapeutics (MAZE) Change in Account Payables (2024 - 2026)
Maze Therapeutics (MAZE) reported Change in Account Payables of $2.2 million for Q1 2026, up 282.04% on a YoY basis from $579000.0 in Q1 2025, and up 296.62% sequentially from -$1.1 million in Q4 2025.
Maze Therapeutics (MAZE) Change in Account Payables (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Change in Account Payables data on file, last reported at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 282.04% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 159.87% YoY), and the FY2025 full-year result was -$27000.0, up 86.76% from the prior year.
- Change in Account Payables grew to $2.2 million in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q1 2026 to a low of -$1.2 million in Q3 2024.
- A 3-year average of $220111.1 and a median of $387000.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 338.27% in 2025, while the deepest fall reached 237.03% in 2025.
- Tracing MAZE's Change in Account Payables over 3 years: stood at $821000.0 in 2024, then slumped by 237.03% to -$1.1 million in 2025, then jumped by 296.62% to $2.2 million in 2026.
- Business Quant data shows MAZE's Change in Account Payables at $2.2 million in Q1 2026, -$1.1 million in Q4 2025, and -$748000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.86 Mn |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | 2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.21 Mn |
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -748,000.00 |
| Sep 30, 2025 | -748,000.00 |
| Jun 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 579,000.00 |
| Mar 31, 2025 | 579,000.00 |
| Dec 31, 2024 | 821,000.00 |
| Dec 31, 2024 | 821,000.00 |
| Sep 30, 2024 | -1.17 Mn |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | -243,000.00 |
| Mar 31, 2024 | -243,000.00 |